Evaluating the Effect of Sodium Phenylbutyrate and Taurursodiol on Survival Outcomes in Amyotrophic Lateral Sclerosis Using a Propensity Score–Matched Cohort From the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Database (S33.005)

Sabrina Paganoni,Merit Cudkowicz,Jamie Timmons,Yuehui Wu,Melanie Quintana

doi:10.1212/wnl.0000000000201898

Evaluating the Effect of Sodium Phenylbutyrate and Taurursodiol on Survival Outcomes in Amyotrophic Lateral Sclerosis Using a Propensity Score–Matched Cohort From the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Database (S33.005)

Sabrina Paganoni, Merit Cudkowicz + Show 3 more

https://doi.org/10.1212/wnl.0000000000201898

Copy DOI

Export

Save

Cite

Journal: Neurology

Publication Date: Apr 25, 2023

Affiliation: Massachusetts General Hospital, Amplyx Pharmaceuticals (United States), Berry & Associates (United States)

#Received Research Support #Pooled Resource Open-Access Amyotrophic Lateral Sclerosis Clinical Trials #Resource Open-Access Amyotrophic Lateral Sclerosis Clinical Trials #Pooled Resource Open-Access Amyotrophic Lateral Sclerosis Clinical #Open-Access Amyotrophic Lateral Sclerosis Clinical Trials Database #Amyotrophic Lateral Sclerosis #Outcomes In Amyotrophic Lateral Sclerosis #Longer Median Survival Time #Propensity Score #Long-term Open-label Extension

Abstract
Full-Text
Similar Papers

Abstract

Listen

Evaluating the Effect of Sodium Phenylbutyrate and Taurursodiol on Survival Outcomes in Amyotrophic Lateral Sclerosis Using a Propensity Score–Matched Cohort From the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Database (S33.005)

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Neurology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Evaluating the Effect of Sodium Phenylbutyrate and Taurursodiol on Survival Outcomes in Amyotrophic Lateral Sclerosis Using a Propensity Score–Matched Cohort From the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Database (S33.005)